Table 1: Patient characteristics at baseline.
| Patients number | 24 |
| Males/females | 15/9 |
| Age (mean ± SD) | 63 ± 12 |
| Causes of ESRD | |
| Diabetes mellitus | 8 |
| Glomerulonephritis | 5 |
| PKD | 2 |
| Interstitial nephritis | 3 |
| Unknown | 5 |
| Secondary amyloidosis | 1 |
| PD treatment | |
| CAPD | 9 |
| CCPD | 15 |
| Treated with oral iron | 7/24 |
| Treated with ESA | 20/24 |
| Weekly mean doses of ESA (darbepoetin: mcg) | 20 ± 18 |
ESRD: End stage renal disease; PKD: Polycystic kidney disease; PD: Peritoneal dialysis; CAPD: Continuous ambulatory peritoneal dialysis; CCPD: Continuous cycler peritoneal dialysis; ESA: Erythropoiesis-stimulating agent.